Split History
SLS split history picture
SELLAS Life Sciences Group (SLS) has 2 splits in our SLS split history database. The first split for SLS took place on January 02, 2018. This was a 1 for 30 reverse split, meaning for each 30 shares of SLS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split. SLS's second split took place on November 08, 2019. This was a 1 for 50 reverse split, meaning for each 50 shares of SLS owned pre-split, the shareholder now owned 1 share. For example, a 33.3333333333333 share position pre-split, became a 0.666666666666667 share position following the split.

When a company such as SELLAS Life Sciences Group conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SLS split history from start to finish, an original position size of 1000 shares would have turned into 0.666666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SELLAS Life Sciences Group shares, starting with a $10,000 purchase of SLS, presented on a split-history-adjusted basis factoring in the complete SLS split history. SLS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/20/2014
End date: 05/17/2024
Start price/share: $3,150.00
End price/share: $1.46
Dividends collected/share: $0.00
Total return: -99.95%
Average Annual Total Return: -53.59%
Starting investment: $10,000.00
Ending investment: $4.64
Years: 10.00
SELLAS Life Sciences Group is a late-stage clinical biopharmaceutical company focused on developing cancer immunotherapeutics for a range of cancer indications. Co.'s product candidates include galinpepimut-S (GPS) and nelipepimut-S (NPS). Co.'s primary product candidate, GPS, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets the Wilms tumor 1 protein, which is present in 20 or more cancer types. NPS is a cancer immunotherapy targeting the human epidermal growth factor receptor 2 expressing cancers. According to our SLS split history records, SELLAS Life Sciences Group has had 2 splits.
Date Ratio
01/02/20181 for 30
11/08/20191 for 50
SLS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SLXP Split History
SNGX Split History
SNOA Split History
SNSS Split History
SRDX Split History
SRPT Split History
SRRA Split History
SSH Split History
SSKN Split History
STAA Split History

Also explore: SLS shares outstanding history

Email EnvelopeFree SLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
Chimera Investment Corporation (CIM)
Advent Technologies Holdings, Inc. (ADN)
Telesis Bio Inc. (TBIO)
United States Lime & Minerals, Inc. (USLM)
Inspire Veterinary Partners, Inc. (IVP)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SLS Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.